Condition

Stage III Lung Cancer

ClinicalTrials.gov condition label

Clinical trials12
Recruiting2
Common interventions25
Lead sponsors shown10

Clinical trials

12 shown
Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLCNCT06878274 · 2026-01-29
RECRUITING
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung CancerNCT05501665 · 2023-05-09
RECRUITING
Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer SurvivorsNCT06654245 · 2025-06-11
TERMINATED
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care ResourcesNCT06383988 · 2024-11-11
ACTIVE_NOT_RECRUITING
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsNCT04985357 · 2024-11-01
WITHDRAWN
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC PatientsNCT06538038 · 2024-09-17
ACTIVE_NOT_RECRUITING
Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung CancerNCT06140407 · 2024-02-14
TERMINATED
Ask Questions (ASQ):Implementation of a Communication InterventionNCT05025748 · 2021-08-25
COMPLETED
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLCNCT05641870 · 2021-02-01
UNKNOWN
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersNCT03112668 · 2017-12-06
COMPLETED
External ValidatIon Trial of ASTER TrialNCT01332240 · 2011-04-01
UNKNOWN
Lung Cancer Informational Study (LCIS)NCT00579215 · 2006-11-01
COMPLETED

Common interventions

Biospecimen CollectionPROCEDURE2CarboplatinDRUG2Computed TomographyPROCEDURE2PembrolizumabBIOLOGICAL2Positron Emission TomographyPROCEDURE2Radiation TherapyRADIATION2[18-F] (fluoropropyl)-L-glutamate (FSPG) PET scanOTHER1AtezolizumabBIOLOGICAL1Behavioral InterventionBEHAVIORAL1CemiplimabBIOLOGICAL1Characterization of the tumoral tissue genomic alterationsDIAGNOSTIC_TEST1Chemoradiation treatment regimen and maintenance (if amenable)DRUG1CisplatinDRUG1Cognitive Behavior TherapyBEHAVIORAL1Electronic health record reviewOTHER1Endoscopic ultrasonographyPROCEDURE1Enhance CareBEHAVIORAL1EtoposideDRUG1Fludeoxyglucose F-18OTHER1Genomic and methylation analysis in liquid biopsyDIAGNOSTIC_TEST1Internet-Based Intervention - CONNECTOTHER1IpilimumabBIOLOGICAL1Magnetic Resonance ImagingPROCEDURE1Nab-paclitaxelDRUG1NivolumabBIOLOGICAL1

Trial status mix

COMPLETED3
ACTIVE_NOT_RECRUITING2
RECRUITING2
TERMINATED2
UNKNOWN2
WITHDRAWN1

Phase mix

NA6
PHASE23
PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.